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The University of Dayton

News Release
Feb. 19, 1993 ·
Contact: Rosemary Harty

CERAMIC CAPSULE DELIVERY COULD SAVE COSTS,
EASE SIDE EFFECTS OF AIDS-FIGHTING DRUG
DAYTON, Ohio-- A Dayton biologist who developed a drug delivery system using
ceramic capsules implanted in the body says the system could cut to 10 percent the current
costs of AZT treatment and reduce harmful side effects including nausea and anemia.
Praphulla K. Bajpai, professor of biology at the University of Dayton, says
experiments with rats indicate a smaller amount of the drug implanted under the skin can
achieve the same dosage level needed in AZT treatment. H.A. Benghuzzi, now a professor at .
the University of Michigan, conducted the studies at UD under Bajpai's direction.
The rats displayed none of the harmful side effects while maintaining constant levels
of the drug in their blood for 60 days.
Bajpai has now begun laboratory tests to adapt the system for delivering effective
levels of AZT in large animals. He will then explore the feasibility of conducting tests in
humans .
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AZT (azidothymidine) is usually given to patients orally, in pill form, and
intravenously to infants suffering from AIDS. Side effects from oral treatment include
swollen tongues, bleeding gums, mouth ulcer and a number of gastrointestinal problems.
-more-
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The drug can also suppress bone marrow, leading to anemia, Bajpai said.
I

Ceramic delivery could avoid such side effects, Bajpai's research shows, because the
large fluctuations in drug concentration in the blood stream and tissues would be eliminated
using the capsules. "With the ceramic capsules you are always within the therapeutic range
and there is no waste of the drug," he said.
The tremendous cost of AZT has been a subject of controversy since the drug first
was shown to be effective in fighting AIDS in the mid-1980s. The cost on the market is now
$250 a gram, Bajpai said, and AZT treatment typically costs about $3,000 per year. If
Bajpai's system proves effective in humans, the dosage could be cut by one-tenth to onetwentieth to achieve the same therapeutic level.
The capsules are implanted in spots such as the fleshy underside of an arm. The rate
of dosage is determined by how porous the ceramic capsule is, Bajpai said. The microscopic
pores and particles of the ceramic can distinguish between chemicals to deliver two or three
drugs at the same time at different rates.
UD first developed the aluminum-calcium-phosphorous oxide (alcap) ceramics as a
substitute for traumatized bone. Bajpai then adapted the ceramics developed at the University
for drug-delivery systems. The capsules are completely absorbed by the body with no
harmful side effects.
A donation of AZT from Burroughs Welcome Co. has helped make the research at
UD possible, Bajpai said, although he's still exploring further funding sources. Honors
biolog~student

Beth Nagy is working with Bajpai on the laboratory test. Bajpai plans to

launch large animal testing of the system with another university or a government partner.
The use of the implants in AZT patients is probably still a few years away, he said.
- 30For more information or for copies of the AZT studies, contact Praphulla K. Bajpai at (513)
229-3029.

